These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26496203)

  • 21. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
    Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cryopreservation of Circulating Tumor Cells for Enumeration and Characterization.
    Nejlund S; Smith J; Kraan J; Stender H; Van MN; Langkjer ST; Nielsen MT; Sölétormos G; Hillig T
    Biopreserv Biobank; 2016 Aug; 14(4):330-7. PubMed ID: 27092845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells.
    Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT
    PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression profiling of circulating tumor cells in metastatic breast cancer.
    Lang JE; Scott JH; Wolf DM; Novak P; Punj V; Magbanua MJ; Zhu W; Mineyev N; Haqq CM; Crothers JR; Esserman LJ; Tripathy D; van 't Veer L; Park JW
    Breast Cancer Res Treat; 2015 Jan; 149(1):121-31. PubMed ID: 25432738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Classification of large circulating tumor cells isolated with ultra-high throughput microfluidic Vortex technology.
    Che J; Yu V; Dhar M; Renier C; Matsumoto M; Heirich K; Garon EB; Goldman J; Rao J; Sledge GW; Pegram MD; Sheth S; Jeffrey SS; Kulkarni RP; Sollier E; Di Carlo D
    Oncotarget; 2016 Mar; 7(11):12748-60. PubMed ID: 26863573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay.
    Soler A; Cayrefourcq L; Mazel M; Alix-Panabières C
    Methods Mol Biol; 2017; 1634():263-276. PubMed ID: 28819858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of hormone receptor status between circulating tumor cells, primary tumor, and metastasis in breast cancer patients.
    Kalinsky K; Mayer JA; Xu X; Pham T; Wong KL; Villarin E; Pircher TJ; Brown M; Maurer MA; Bischoff FZ
    Clin Transl Oncol; 2015 Jul; 17(7):539-46. PubMed ID: 25613123
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of a multiplexed immunoassay (PRO Onc assay) to detect HER2 abnormalities in circulating tumor cells of women with HER2-negative metastatic breast cancer: lack of response to HER2-targeted therapy.
    Hainsworth JD; Murphy PB; Alemar JR; Daniel BR; Young RR; Yardley DA
    Breast Cancer Res Treat; 2016 Nov; 160(1):41-49. PubMed ID: 27632289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD49f-based selection of circulating tumor cells (CTCs) improves detection across breast cancer subtypes.
    Mostert B; Kraan J; Sieuwerts AM; van der Spoel P; Bolt-de Vries J; Prager-van der Smissen WJ; Smid M; Timmermans AM; Martens JW; Gratama JW; Foekens JA; Sleijfer S
    Cancer Lett; 2012 Jun; 319(1):49-55. PubMed ID: 22202642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low.
    Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE
    Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcripts of circulating tumor cells detected by a breast cancer-specific platform correlate with clinical stage in bladder cancer patients.
    Todenhöfer T; Hennenlotter J; Dorner N; Kühs U; Aufderklamm S; Rausch S; Bier S; Mischinger J; Schellbach D; Hauch S; Feniuk N; Bedke J; Gakis G; Stenzl A; Schwentner C
    J Cancer Res Clin Oncol; 2016 May; 142(5):1013-20. PubMed ID: 26910601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.
    Payne RE; Yagüe E; Slade MJ; Apostolopoulos C; Jiao LR; Ward B; Coombes RC; Stebbing J
    Pharmacogenomics; 2009 Jan; 10(1):51-7. PubMed ID: 19102715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Size-selective collection of circulating tumor cells using Vortex technology.
    Sollier E; Go DE; Che J; Gossett DR; O'Byrne S; Weaver WM; Kummer N; Rettig M; Goldman J; Nickols N; McCloskey S; Kulkarni RP; Di Carlo D
    Lab Chip; 2014 Jan; 14(1):63-77. PubMed ID: 24061411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Label-Free Isolation and mRNA Detection of Circulating Tumor Cells from Patients with Metastatic Lung Cancer for Disease Diagnosis and Monitoring Therapeutic Efficacy.
    Wang J; Lu W; Tang C; Liu Y; Sun J; Mu X; Zhang L; Dai B; Li X; Zhuo H; Jiang X
    Anal Chem; 2015 Dec; 87(23):11893-900. PubMed ID: 26531886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A subpopulation of circulating endothelial cells express CD109 and is enriched in the blood of cancer patients.
    Mancuso P; Calleri A; Gregato G; Labanca V; Quarna J; Antoniotti P; Cuppini L; Finocchiaro G; Eoli M; Rosti V; Bertolini F
    PLoS One; 2014; 9(12):e114713. PubMed ID: 25506915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A microchip filter device incorporating slit arrays and 3-D flow for detection of circulating tumor cells using CAV1-EpCAM conjugated microbeads.
    Kim YJ; Koo GB; Lee JY; Moon HS; Kim DG; Lee DG; Lee JY; Oh JH; Park JM; Kim MS; Woo HG; Kim SI; Kang P; Choi W; Sim TS; Park WY; Lee JG; Kim YS
    Biomaterials; 2014 Aug; 35(26):7501-10. PubMed ID: 24917030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Detection of EMT Markers in Circulating Tumor Cells from Metastatic Non-Small Cell Lung Cancer Patients: Potential Role in Clinical Practice.
    Milano A; Mazzetta F; Valente S; Ranieri D; Leone L; Botticelli A; Onesti CE; Lauro S; Raffa S; Torrisi MR; Marchetti P
    Anal Cell Pathol (Amst); 2018; 2018():3506874. PubMed ID: 29682444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
    Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
    Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
    Lianidou ES; Markou A
    Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.